Prognostic value of copeptin in patients with acute coronary syndrome: A systematic review and meta-analysis

Jiapeng Lu, Siming Wang, Guangda He and Yanping Wang

PLOS ONE, 2020, vol. 15, issue 8, 1-11

Abstract: Background: The aim of this study was to evaluate the value of copeptin in predicting mortality including both short-term and long-term mortality in patients with acute coronary syndrome (ACS). Methods: Potential studies were searched and selected through PubMed, Embase and Cochrane databases up to December 2019. The predictive performance was evaluated by the pooled sensitivity and specificity, and summary receiver operating characteristic curves. Cochran’s Q test and I2 index were used to assess between-study heterogeneity, and Deek’s test and funnel plots were used to assess publication bias. Results: Total six studies comprising 2269 patients were included in this meta-analysis. The area under the receiver operating characteristic curve of copeptin in predicting mortality in patients with ACS was 0.73 (95% CI: 0.69–0.77). The pooled sensitivity and specificity of copeptin were 0.77 (95% CI: 0.59–0.89) and 0.60 (95% CI: 0.47–0.71), respectively. Significant between-study heterogeneity was identified in both sensitivity (P = 0.01; I2 = 69.76%) and specificity (P

Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0238288 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 38288&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0238288

DOI: 10.1371/journal.pone.0238288

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().